|
|
|
CuraGen Issues 4.8 Million New Shares
|
Business New Haven
11/27/2000
By: BNH
|
NEW HAVEN - CuraGen Corp. (NASDAQ: CRGN) announced November 16 that it had priced its public offering of 4,800,000 newly issued shares of common stock at $41.00 per share. Net proceeds to CuraGen were expected to be approximately $186.5 million. The offering was jointly lead-managed by Morgan Stanley Dean Witter and Lehman Brothers, and co-managed by Dain Rauscher Wessels; Bear, Stearns & Co. Inc.; Prudential Vector Healthcare (a unit of Prudential Securities); and Thomas Weisel Partners LLC. CuraGen granted the underwriters an option to purchase up to 720,000 additional shares to cover any over-allotments. CuraGen is an integrated genomics-based drug discovery and development company advancing the discovery and development of pharmaceutical and life science products through the systematic application of genomics.
|
Go FirstGo PreviousGo
NextGo LastGo
to Index
|
|
